| Dr Rachel Michal Ellis, MD | |
|
620 John Paul Jones Cir, Portsmouth, VA 23708-2111 | |
| (757) 953-9808 | |
| Not Available |
| Full Name | Dr Rachel Michal Ellis |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891051298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 0101260202 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Dermatology, Inc. | 7012071608 | 6 |
News Archive
"The Every Child Deserves a 5th Birthday theme for this week is prevention of mother-to-child transmission of HIV (PMTCT)," an e-mail alert from USAID reports, noting, "PMTCT provides HIV prevention, treatment, care, and support services for the whole family and is the most effective way to create an HIV-free generation."
Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).
Parents may require help obtaining complete medical records and understanding what is in them after a child suffers birth-related complications and injury, says birth injury attorney Kenneth Suggs.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
› Verified 1 days ago
| Entity Name | Pariser Dermatology Specialists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417047952 PECOS PAC ID: 7113902925 Enrollment ID: O20040623001559 |
News Archive
"The Every Child Deserves a 5th Birthday theme for this week is prevention of mother-to-child transmission of HIV (PMTCT)," an e-mail alert from USAID reports, noting, "PMTCT provides HIV prevention, treatment, care, and support services for the whole family and is the most effective way to create an HIV-free generation."
Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).
Parents may require help obtaining complete medical records and understanding what is in them after a child suffers birth-related complications and injury, says birth injury attorney Kenneth Suggs.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
› Verified 1 days ago
| Entity Name | Atlantic Dermatology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033159454 PECOS PAC ID: 2961455076 Enrollment ID: O20050301000793 |
News Archive
"The Every Child Deserves a 5th Birthday theme for this week is prevention of mother-to-child transmission of HIV (PMTCT)," an e-mail alert from USAID reports, noting, "PMTCT provides HIV prevention, treatment, care, and support services for the whole family and is the most effective way to create an HIV-free generation."
Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).
Parents may require help obtaining complete medical records and understanding what is in them after a child suffers birth-related complications and injury, says birth injury attorney Kenneth Suggs.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
› Verified 1 days ago
| Entity Name | Associates In Dermatology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609912112 PECOS PAC ID: 7012071608 Enrollment ID: O20090126000746 |
News Archive
"The Every Child Deserves a 5th Birthday theme for this week is prevention of mother-to-child transmission of HIV (PMTCT)," an e-mail alert from USAID reports, noting, "PMTCT provides HIV prevention, treatment, care, and support services for the whole family and is the most effective way to create an HIV-free generation."
Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).
Parents may require help obtaining complete medical records and understanding what is in them after a child suffers birth-related complications and injury, says birth injury attorney Kenneth Suggs.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Michal Ellis, MD Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708-2197 Ph: (757) 953-9808 | Dr Rachel Michal Ellis, MD 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-9808 |
News Archive
"The Every Child Deserves a 5th Birthday theme for this week is prevention of mother-to-child transmission of HIV (PMTCT)," an e-mail alert from USAID reports, noting, "PMTCT provides HIV prevention, treatment, care, and support services for the whole family and is the most effective way to create an HIV-free generation."
Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).
Parents may require help obtaining complete medical records and understanding what is in them after a child suffers birth-related complications and injury, says birth injury attorney Kenneth Suggs.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
› Verified 1 days ago
Dr. Anis Miladi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0311 | |
Dr. Megan Ann Brelsford, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Charette Health Care Center, Portsmouth, VA 23708 Phone: 757-953-0291 Fax: 757-953-0862 | |
Dr. Margaret Cecilia Green, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir Bldg 3, Portsmouth, VA 23708 Phone: 757-953-0307 | |
Dr. Trisha Clarke Beute, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Nmcp- Dept Of Dermatology, Portsmouth, VA 23708 Phone: 757-953-0311 | |
John Peters, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0291 | |
Dr. Aaron Cantor, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir Ste 275, Portsmouth, VA 23708 Phone: 757-953-5000 |